Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (ZAX)37,021.00
  • Today's Change-565.00 / -1.50%
  • Shares traded217.16k
  • 1 Year change+9.69%
  • Beta0.4974
Data delayed at least 15 minutes, as of Jul 04 2025 16:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clicks Group Limited is a retail-led healthcare company. The Company’s brands include Clicks, Clicks Baby, The Body Shop and UPD. Clicks is a pharmacy, health, and beauty retailer with approximately 897 stores and 718 in-store pharmacies. Clicks Baby provides a range of mother and baby products, including baby hardware, accessories, health, foods, diapers and wipes and baby toiletries. The Body Shop is a global brand which markets beauty products, focusing primarily on the middle to upper income groups. The Clicks Group manages The Body Shop under a franchise arrangement in South Africa. UPD is a full-line pharmaceutical wholesaler and supplies retail pharmacies, private hospitals, dispensing doctors, and retail health stores. UPD also provides bulk distribution services to pharmaceutical manufacturers. Its stores outside South Africa are in the neighboring countries of Namibia, Botswana, Eswatini, and Lesotho.

  • Revenue in ZAR (TTM)46.80bn
  • Net income in ZAR3.00bn
  • Incorporated1996
  • Employees19.73k
  • Location
    Clicks Group LtdCnr. Searle and Pontac Streets,PO Box 5142CAPE TOWN 8000South AfricaZAF
  • Phone+27 214601911
  • Fax+27 214601805
  • Websitehttps://www.clicksgroup.co.za/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dis-Chem Pharmacies Ltd39.17bn1.18bn27.91bn18.50k23.605.3311.800.71251.371.3745.656.092.134.0312.96--6.636.4414.0313.6422.4722.623.112.940.39694.480.543929.307.9610.3119.8414.5531.0133.79
Clicks Group Ltd46.80bn3.00bn87.72bn19.73k29.3713.7918.251.8712.6012.60196.5826.852.384.6017.052,385,090.0015.2713.5734.6531.1623.6121.766.415.990.423715.900.390662.149.177.7011.8011.036.6211.76
Data as of Jul 04 2025. Currency figures normalised to Clicks Group Ltd's reporting currency: South African Rand ZAR

Institutional shareholders

47.10%Per cent of shares held by top holders
HolderShares% Held
Public Investment Corporation (SOC) Ltd.as of 04 Mar 202547.93m20.14%
JPMorgan Asset Management (UK) Ltd.as of 31 Aug 202412.86m5.40%
RBC Global Asset Management (UK) Ltd.as of 24 Oct 202411.97m5.03%
GIC Pte Ltd. (Investment Management)as of 31 Aug 202410.71m4.50%
The Vanguard Group, Inc.as of 04 Jun 20258.93m3.75%
Ninety One SA (Pty) Ltd.as of 31 Dec 20245.56m2.33%
BlackRock Fund Advisorsas of 05 Jun 20254.61m1.94%
Handelsbanken Fonder ABas of 30 Jun 20253.60m1.51%
Lazard Asset Management LLCas of 31 May 20253.21m1.35%
BlackRock Advisors (UK) Ltd.as of 06 Jun 20252.75m1.15%
More ▼
Data from 31 Mar 2025 - 02 Jul 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.